• Monte Rosa Therapeutics Chief Medical Officer Filip Janku sold 5,407 shares on June 30 at USD 24.5.
• He acquired 5,407 shares at USD 13.41 via option exercise on the same day.
• Directly held common stock totaled 60,612 shares following the transactions.
• Directly held stock options totaled 81,093 following the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monte Rosa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-292767), on July 01, 2026, and is solely responsible for the information contained therein.